CRISPR Therapeutics AG
CRSP · XNASCIK 1674416fmd_1P4Z68KQ4HJ7G7B6WN1NKPHAB1Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2014 to Sep 30, 2026, 48 periods
News summary
An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.
AI-written
0 filings
From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).
Loading